Stepman H C M, Thienpont LM (2009) Measurement uncertainty for the analysis of serum 25-hydroxyvitamin D. Osteoporos Int doi:10.1007/s00198-009- 1099-3 (in press)
Cavalier E, Rozet E, Gadisseur R, Carlisi A, Monge M, Chapelle JP, Hubert P, Souberbielle JC, Delanaye P (2009) Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos Int doi:10.1007/s00198-009-1052-5 (in press)
Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P (2003) Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 49:1381-1395
Hathcock JN, Shao A, Vieth R, Heaney R (2007) Risk assessment for vitamin D. Am J Clin Nutr 85:6-18
Heaney RP (2008) Vitamin D: criteria for safety and efficacy. Nutr Rev 66: S178-S181
Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18-28
McKenna MJ, Freaney R (1998) Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8 (Suppl 2): S3-S6
Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501
Binkley N, Krueger D (2008) Evaluation and correction of low vitamin D status. Curr Osteoporos Rep 6:95-99